Recent research has investigated the potential link between viral respiratory infections and the metastasis of dormant disseminated cancer cells (D...
A new treatment for bladder cancer, combining enfortumab vedotin with pembrolizumab, has been approved for use by the NHS in England. This therapy ...
A study has identified MCL1 as a potential therapeutic target in CIC::DUX4 rearranged sarcoma using patient-derived tumoroid models. These models w...
New research published in Nature Communications reveals that certain breast cancer tumors may utilize neighboring fat cells as an energy source, po...
A recent study has examined the long-term survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who rel...
Anixa Biosciences has announced the treatment of the second patient in the fourth cohort of its Phase 1 clinical trial for a novel CAR-T therapy ta...
Anixa Biosciences has treated the second patient in the fourth cohort of its Phase 1 clinical trial for ovarian cancer CAR-T therapy. The trial, co...
The Lung Cancer Research Foundation (LCRF) has announced the expansion of its Scientific Advisory Board (SAB) by adding five new members. This move...
Northwest Biotherapeutics, a biotechnology company specializing in personalized immune therapies for solid tumor cancers, has announced the passing...
Recent advancements in cancer immunology have identified various phagocytosis checkpoints that play a crucial role in tumor cell survival and immun...